Abstract
Different estimates of the rate constant for the effect site distribution (ke0) of propofol, depending on the rate and duration of administration, have been reported. This analysis aimed at finding a more general pharmacodynamic model that could be used when the rate of administration is changed during the treatment. In a cross-over study, 21 healthy volunteers were randomised to receive a 1 min infusion of 2 mg/kg of propofol at one occasion, and a 1 min infusion of 2 mg/kg of propofol immediately followed by a 29 min infusion of 12 mg kg−1 h−1 of propofol at another occasion. Arterial plasma concentrations of propofol were collected up to 4 h after dosing, and BIS was collected before start of infusion and until the subjects were fully awake. The population pharmacokinetic-pharmacodynamic analysis was performed using NONMEM VI. A four-compartment PK model with time-dependent elimination and distribution described the arterial propofol concentrations, and was used as input to the pharmacodynamic model. A standard effect compartment model could not accurately describe the delay in the effects of propofol for both regimens, whereas a two-compartment effect site model significantly improved the predictions. The two-compartment effect site model included a central and a peripheral effect site compartment, possibly representing a distribution within the brain, where the decrease in BIS was linked to the central effect site compartment concentrations through a sigmoidal Emax model.
Similar content being viewed by others
References
Gepts E, Camu F, Cockshott ID, Douglas EJ (1987) Disposition of propofol administered as constant rate infusions in humans. Anesth Analg 66:1256–1263
Marsh B, White M, Morton N, Kenny GNC (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67:41–48
Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88:1170–1182
Schüttler J, Ihmsen H (2000) Population pharmacokinetics of propofol. Anesthesiology 92:727–738
Kazama T, Ikeda K, Morita K, Kikura M, Ikeda T, Kurita T, Sato S (2000) Investigation of effective anesthesia induction doses using a wide range of infusion rates with undiluted and diluted propofol. Anesthesiology 92:1017–1028
Billard V, Gambus PL, Chamoun N, Stanski DR, Shafer SL (1997) A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharmacol Ther 61:45–58
Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90:1502–1516
Struys MMRF, De Smeet T, Depoorter B, Versichelen LFM, Mortier EP, Dumortier FJE, Shafer SL, Rolly G (2000) Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 92:399–406
Doufas AG, Bakhshandeh M, Bjorksten AR, Shafer SL, Sessler DI (2004) Induction speed is not a determinant of propofol pharmacodynamics. Anesthesiology 101:1112–1121
Struys MMRF, Coppens MJ, De Neve N, Mortier EP, Doufas AG, Van Bocxlaer JFP, Shafer SL (2007) Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology 107:386–396
Jeleazcov C, Ihmsen H, Schmidt J, Ammon C, Schwilden H, Shüttler J, Fechner J (2008) Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children. Br J Anaesth 100:509–516
Upton RN, Ludbrook G (2005) A physiologically based, recirculatory model of the kinetics and dynamics of propofol in man. Anesthesiology 103:344–352
Masui K, Kira M, Kazama T, Hagihira S, Mortier EP, Struys MMRF (2009) Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate. Anesthesiology 111:805–817
Upton RN, Ludbrook GL, Grant C, Martinez AM (1999) Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. Anesth Analg 89:545–552
Peeters MYM, Aarts LPHJ, Boom FA, Bras LJ, Tibboel D, Danhof M, Knibbe CAJ (2008) Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients. Eur J Clin Pharmacol 64:329–334
Levitt DG, Schnider TW (2005) Human physiologically based pharmacokinetic model for propofol. BMC Anesth 5:4
Minto CF, Schnider TW (2008) Contributions of PK/PD modelling to intravenous anesthesia. Clin Pharmacol Ther 84:27–38
Dawidowicz AL, Fijalkowska A (1995) Determination of propofol in blood by HPLC. Comparison of the extraction and precipitation methods. J Chromatogr Sci 33:377–382
Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL (1990) Validity and reliability of the observer’s assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 10:244–251
Beal SL, Sheiner LB, Boeckmann AJ (eds) (1989–2006) NONMEM users guides. ICON Development Solutions, Ellicott City
Jonsson EN, Karlsson MO (1999) Xpose—an S-PLUS population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58:51–64
Lindbom L, Pihlgren P, Jonsson EN (2005) PsN-toolkit—a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 79:241–257
Karlsson MO, Holford N (2008) A tutorial on visual predictive checks. Abstract 1434, p 17. www.page-meeting.org/?abstract=1434
Upton RN, Ludbrook GL, Grant C (2001) The cerebral and systemic kinetics of thiopentone and propofol in halothane anaesthetized sheep. Anaesth Intensive Care 29:117–123
Peacock JE, Blackburn A, Sherry KM, Reilly CS (1995) Arterial and jugular venous bulb blood propofol concentrations during induction of anesthesia. Anesth Analg 80:1002–1006
Dutta S, Matsumoto Y, Muramatsu A, Matsumoto M, Fukuoka M, Ebling WF (1998) Steady-state propofol brain: plasma and brain: blood partition coefficients and the effect-site equilibration paradox. Br J Anaesth 81:422–424
Ludbrook GL, Visco E, Lam AM (2002) Propofol: relation between brain concentrations, electroencephalogram, middle cerebral artery blood flow velocity, and cerebral oxygen extraction during induction of anesthesia. Anesthesiology 97:1363–1370
Zamacona MK, Suárez E, García E, Aguirre C, Calvo R (1998) The significance of lipoproteins in serum binding variations of propofol. Anesth Analg 87:1147–1151
Weaver BMQ, Staddon GE, Mapleson WW (2001) Tissue/blood and tissue/water partition coefficients for propofol in sheep. Br J Anaesth 86:693–703
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Björnsson, M.A., Norberg, Å., Kalman, S. et al. A two-compartment effect site model describes the bispectral index after different rates of propofol infusion. J Pharmacokinet Pharmacodyn 37, 243–255 (2010). https://doi.org/10.1007/s10928-010-9157-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-010-9157-1